Kuntai capsules improve glucolipid metabolism in patients with polycystic ovary syndrome: A randomized, double-blind, placebo-controlled trial

BACKGROUND: The aim of this study was to observe the effect and safety of Heyan Kuntai Capsule (HYKT) on glucose and lipid metabolism in patients with polycystic ovary syndrome (PCOS). METHODS: Hundred patients with PCOS were randomly divided into HYKT group (n = 50) and placebo groups (n = 50) in w...

Descripción completa

Detalles Bibliográficos
Autores principales: Liang, Ruining, Liu, Zhen, Li, Peishuang, Fan, Pei, Xu, Ling, Sun, Xueyan, Peng, Jiahua, Peng, Xuemei, Zhang, Meinan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Wolters Kluwer Health 2019
Materias:
5600
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6775382/
https://www.ncbi.nlm.nih.gov/pubmed/31574794
http://dx.doi.org/10.1097/MD.0000000000016788

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6775382/
https://www.ncbi.nlm.nih.gov/pubmed/31574794
http://dx.doi.org/10.1097/MD.0000000000016788

Ejemplares similares